Clinical Trial Update: Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

View source ↗

Summary

A clinical trial is investigating the effectiveness and safety of the CAR-T therapy tisagenlecleucel in Brazilian patients with B-lymphocyte malignancies, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• Kymriah (tisagenlecleucel) (tisagenlecleucel)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia | Status: RECRUITING